US3919205A
(en)
|
1972-07-17 |
1975-11-11 |
Squibb & Sons Inc |
Dithiocarbonylthioacetyl cephalosporin derivatives
|
US5166331A
(en)
|
1983-10-10 |
1992-11-24 |
Fidia, S.P.A. |
Hyaluronics acid fractions, methods for the preparation thereof, and pharmaceutical compositions containing same
|
FR2654725B1
(fr)
|
1989-11-23 |
1992-02-14 |
Rhone Poulenc Sante |
Nouveaux derives de l'isoindolone, leur preparation et les compositions pharmaceutiques qui les contiennent.
|
US5420297A
(en)
|
1990-10-24 |
1995-05-30 |
Fujisawa Pharmaceutical Co., Ltd. |
Peptides having substance P antagonistic activity
|
FR2676055B1
(fr)
|
1991-05-03 |
1993-09-03 |
Sanofi Elf |
Composes polycycliques amines et leurs enantiomeres, procede pour leur preparation et compositions pharmaceutiques les contenant.
|
UA27776C2
(uk)
|
1991-05-31 |
2000-10-16 |
Пфайзер Інк. |
Похідні хінуклідину та їх фармацевтично прийнятні солі, що є антагоністами речовини р у ссавців, фармацевтична композиція, що має антагоністичну дію на речовину р у ссавців
|
GB9113219D0
(en)
|
1991-06-19 |
1991-08-07 |
Fujisawa Pharmaceutical Co |
Peptide compound,processes for preparation thereof and pharmaceutical composition comprising the same
|
EP0522808A3
(en)
|
1991-07-05 |
1993-01-27 |
MERCK SHARP & DOHME LTD. |
Aromatic compounds, pharmaceutical compositions containing them and their use in therapy
|
US5552534A
(en)
|
1991-08-22 |
1996-09-03 |
The Trustees Of The University Of Pennsylvania |
Non-Peptide peptidomimetics
|
EP0533280B2
(en)
|
1991-09-20 |
2004-12-01 |
Glaxo Group Limited |
Novel medical use for tachykinin antagonists
|
GB9200535D0
(en)
|
1992-01-10 |
1992-02-26 |
Fujisawa Pharmaceutical Co |
New compound
|
WO1993017032A1
(en)
|
1992-02-24 |
1993-09-02 |
The Trustees Of The University Of Pennsylvania |
Techniques and intermediates for preparing non-peptide peptidomimetics
|
FR2689889B1
(fr)
|
1992-04-10 |
1994-06-10 |
Rhone Poulenc Rorer Sa |
Nouveaux derives de perhydroisoindole, et leur preparation.
|
TW241258B
(zh)
|
1992-04-15 |
1995-02-21 |
Takeda Pharm Industry Co Ltd |
|
US6048859A
(en)
|
1992-06-29 |
2000-04-11 |
Merck & Co., Inc. |
Morpholine and thiomorpholine tachykinin receptor antagonists
|
US5719147A
(en)
|
1992-06-29 |
1998-02-17 |
Merck & Co., Inc. |
Morpholine and thiomorpholine tachykinin receptor antagonists
|
IL111002A
(en)
|
1993-09-22 |
1998-09-24 |
Glaxo Group Ltd |
History of piperidine, their preparation and the pharmaceutical preparations containing them
|
US6403577B1
(en)
|
1993-11-17 |
2002-06-11 |
Eli Lilly And Company |
Hexamethyleneiminyl tachykinin receptor antagonists
|
IL111730A
(en)
|
1993-11-29 |
1998-12-06 |
Fujisawa Pharmaceutical Co |
Piperazine derivatives, processes for their preparation and pharmaceutical preparations containing them
|
IL112778A0
(en)
|
1994-03-04 |
1995-05-26 |
Merck & Co Inc |
Substituted heterocycles, their preparation and pharmaceutical compositions containing them
|
FR2718136B1
(fr)
|
1994-03-29 |
1996-06-21 |
Sanofi Sa |
Composés aromatiques aminés, procédé pour leur obtention et compositions pharmaceutiques les contenant.
|
EP0783490B1
(en)
|
1994-09-30 |
2002-02-06 |
Novartis AG |
1-acyl-4-aliphatic aminopiperidine compounds
|
TR199700834T1
(xx)
|
1995-02-22 |
1998-01-21 |
Novartis Ag |
1-Aril-2-Akilamino ethan bile�ikleri ve bunlar�n n�rokinin olarak �zellikle n�rokinin 1 has�mlar� olarak kullan�mlar�.
|
GB9505692D0
(en)
|
1995-03-21 |
1995-05-10 |
Glaxo Group Ltd |
Chemical compounds
|
EP0826684B1
(en)
|
1995-03-27 |
2001-11-21 |
Hisamitsu Pharmaceutical Co., Inc. |
Piperidine derivatives
|
DE19519245C2
(de)
|
1995-04-14 |
2003-04-30 |
Boehringer Ingelheim Kg |
Neue Arylglycinamidderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
|
GB9510600D0
(en)
|
1995-05-25 |
1995-07-19 |
Fujisawa Pharmaceutical Co |
Piperazine derivatives
|
TW382017B
(en)
|
1995-12-27 |
2000-02-11 |
Janssen Pharmaceutica Nv |
1-(1,2-disubstituted piperidinyl)-4-(fused imidazole)-piperidine derivatives
|
DE19608665A1
(de)
|
1996-03-06 |
1997-09-11 |
Boehringer Ingelheim Kg |
Neue Arylglycinamidderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
|
US5929094A
(en)
|
1996-10-25 |
1999-07-27 |
Merck & Co., Inc. |
Heteroaryl spiroethercycloalkyl tachykinin receptor antagonists
|
WO1998017660A1
(en)
|
1996-10-25 |
1998-04-30 |
Merck & Co., Inc. |
Phenyl spiroethercycloalkyl tachykinin receptor antagonists
|
GB9625843D0
(en)
|
1996-12-12 |
1997-01-29 |
Merck & Co Inc |
Phenyl spiroethercycloalkyl tachykinn receptor antagonists
|
GB9700597D0
(en)
|
1997-01-14 |
1997-03-05 |
Sandoz Pharma Uk |
Organic compounds
|
JPH10259184A
(ja)
|
1997-03-18 |
1998-09-29 |
Takeda Chem Ind Ltd |
三環性複素環化合物の製造法
|
ZA985765B
(en)
|
1997-07-02 |
1999-08-04 |
Merck & Co Inc |
Polymorphic form of a tachykinin receptor antagonist.
|
ID24309A
(id)
|
1997-08-06 |
2000-07-13 |
Lilly Co Eli |
2-asilaminopropanamina sebagai antagonis reseptor tachykinin
|
TW426667B
(en)
|
1997-11-19 |
2001-03-21 |
Pfizer |
Piperidinylaminomethyl trifluoromethyl cyclic ether compounds as substance P antagonists
|
GB9905010D0
(en)
|
1999-03-04 |
1999-04-28 |
Merck Sharp & Dohme |
Therapeutic agents
|
US6291465B1
(en)
|
1999-03-09 |
2001-09-18 |
Hoffmann-La Roche Inc. |
Biphenyl derivatives
|
CO5150225A1
(es)
|
1999-03-19 |
2002-04-29 |
Merck Sharp & Dohme |
Derivados del tetrahidropirano y su uso como agentes terapeuticos
|
GB9907571D0
(en)
|
1999-04-06 |
1999-05-26 |
Zeneca Ltd |
Compounds
|
WO2000068292A1
(de)
|
1999-05-10 |
2000-11-16 |
Acordis Industrial Fibers Gmbh |
Fadenbildende polyester und copolyester und verfahren zu deren herstellung
|
JP3229294B2
(ja)
|
1999-06-04 |
2001-11-19 |
キヤノン販売株式会社 |
被成膜面の改質方法及び半導体装置の製造方法
|
GB9923748D0
(en)
|
1999-10-07 |
1999-12-08 |
Glaxo Group Ltd |
Chemical compounds
|
WO2001025233A1
(fr)
|
1999-10-07 |
2001-04-12 |
Hisamitsu Pharmaceutical Co., Inc. |
Derives de piperidine
|
JP2003530381A
(ja)
|
2000-04-06 |
2003-10-14 |
アストラゼネカ・アクチエボラーグ |
化合物
|
ATE400563T1
(de)
|
2000-04-06 |
2008-07-15 |
Astrazeneca Ab |
Neue neurokinin-antagonisten zum gebrauch als arzneimittel
|
GB0012240D0
(en)
|
2000-05-19 |
2000-07-12 |
Merck Sharp & Dohme |
Therapeutic agents
|
CN1327997A
(zh)
|
2000-06-12 |
2001-12-26 |
上海博德基因开发有限公司 |
一种新的多肽——Ras GTP酶激活蛋白9.57和编码这种多肽的多核苷酸
|
DE10036818A1
(de)
|
2000-07-28 |
2002-02-07 |
Solvay Pharm Gmbh |
Neue N-Triazolylmethyl-Piperazinderivate als Neurokininrezeptor-Antagonisten
|
PE20020444A1
(es)
|
2000-09-22 |
2002-06-14 |
Merck & Co Inc |
Antagonistas de receptores de taquiquinina zwitterionica
|
SE0003476D0
(sv)
|
2000-09-28 |
2000-09-28 |
Astrazeneca Ab |
Compounds
|
GB0025354D0
(en)
|
2000-10-17 |
2000-11-29 |
Glaxo Group Ltd |
Chemical compounds
|
US6642226B2
(en)
|
2001-02-06 |
2003-11-04 |
Hoffman-La Roche Inc. |
Substituted phenyl-piperidine methanone compounds
|
GB0108595D0
(en)
|
2001-04-05 |
2001-05-23 |
Glaxo Group Ltd |
Chemical compounds
|
GB0114867D0
(en)
|
2001-06-18 |
2001-08-08 |
Merck Sharp & Dohme |
Therapeutic agents
|
GB0119797D0
(en)
|
2001-08-14 |
2001-10-03 |
Glaxo Group Ltd |
Chemical compounds
|
EP1295599A1
(en)
|
2001-09-21 |
2003-03-26 |
Boehringer Ingelheim International GmbH |
Method for the treatment of prevention of atopic dermatitis
|
PE20030762A1
(es)
|
2001-12-18 |
2003-09-05 |
Schering Corp |
Compuestos heterociclicos como antagonistas nk1
|
JP4417720B2
(ja)
|
2002-01-18 |
2010-02-17 |
杏林製薬株式会社 |
縮合二環式ピリミジン誘導体
|
GB0203022D0
(en)
|
2002-02-08 |
2002-03-27 |
Glaxo Group Ltd |
Chemical compounds
|
JP2005522436A
(ja)
|
2002-02-08 |
2005-07-28 |
グラクソ グループ リミテッド |
ピペリジルカルボキシアミド誘導体またはそのタキキニン介在疾患の治療における使用
|
GB0203020D0
(en)
|
2002-02-08 |
2002-03-27 |
Glaxo Group Ltd |
Chemical compounds
|
JP2004002334A
(ja)
|
2002-03-25 |
2004-01-08 |
Tanabe Seiyaku Co Ltd |
医薬組成物
|
JP4559087B2
(ja)
|
2002-04-26 |
2010-10-06 |
イーライ リリー アンド カンパニー |
タキキニン受容体アンタゴニストとしてのトリアゾール誘導体
|
GB0215392D0
(en)
|
2002-07-03 |
2002-08-14 |
Glaxo Group Ltd |
Chemical compounds
|
ATE453621T1
(de)
|
2002-07-03 |
2010-01-15 |
Glaxo Group Ltd |
Substituierte 4-phenylpiperidinamide als tachykininantagonisten und serotoninwiederaufnahmehemmer
|
GB0217068D0
(en)
|
2002-07-23 |
2002-08-28 |
Merck Sharp & Dohme |
Therapeutic agents
|
GB0220953D0
(en)
|
2002-09-10 |
2002-10-23 |
Novartis Ag |
Organic compounds
|
GB0310724D0
(en)
|
2003-05-09 |
2003-06-11 |
Glaxo Group Ltd |
Chemical compounds
|
WO2005019225A1
(ja)
|
2003-08-21 |
2005-03-03 |
Kyorin Pharmaceutical Co., Ltd. |
Nk1受容体拮抗作用を有する化合物の製造方法及びその製造中間体
|
AR047439A1
(es)
|
2004-01-27 |
2006-01-18 |
Merck & Co Inc |
Antagonistas del receptor hidroisoindolina taquiquinina
|
US8108430B2
(en)
|
2004-04-30 |
2012-01-31 |
Microsoft Corporation |
Carousel control for metadata navigation and assignment
|
GB0412865D0
(en)
|
2004-06-09 |
2004-07-14 |
Glaxo Group Ltd |
Chemical compounds
|
CN101068551A
(zh)
|
2004-12-03 |
2007-11-07 |
默克公司 |
喹啉速激肽受体拮抗剂
|
US20080039494A1
(en)
|
2004-12-03 |
2008-02-14 |
Jianming Bao |
8-Phenyl-5,6,7,8-Hydroquinoline Tachykinin Receptor Antagonists
|
AU2005316676A1
(en)
|
2004-12-14 |
2006-06-22 |
Merck & Co., Inc. |
Octahydropyrano[3,4-c]pyrrole tachykinin receptor antagonists
|
US7354922B2
(en)
|
2004-12-14 |
2008-04-08 |
Schering Corporation |
Bridged ring NK1 antagonists
|
EP1870396B1
(en)
|
2005-03-31 |
2012-10-31 |
Nippon Zoki Pharmaceutical Co. Ltd. |
Benzyloxypropylamine derivative
|
EP1965794A4
(en)
|
2005-12-22 |
2009-10-21 |
Merck & Co Inc |
OCTAHYDROPYRANO [3,4-c] pyrrole tachykinin receptor Antagonist
|
WO2007074491A1
(en)
|
2005-12-28 |
2007-07-05 |
Universita Degli Studi Di Siena |
HETEROTRICYCLIC AMIDE DERIVATIVES AS NEUROKININ-l (NKl) RECEPTOR LIGANDS
|
JP2007277231A
(ja)
|
2006-03-16 |
2007-10-25 |
Tanabe Seiyaku Co Ltd |
医薬組成物
|
US20090286777A1
(en)
|
2006-05-15 |
2009-11-19 |
Jianming Bao |
5,6,Fused Pyrrolidine Compounds Useful as Tachykinin Receptor Antagonists
|
WO2008049842A2
(en)
|
2006-10-26 |
2008-05-02 |
Boehringer Ingelheim International Gmbh |
Egfr kinase inhibitor combinations for the treatment of respiratory and gastrointestinal disorders
|
JP2008239618A
(ja)
|
2007-02-28 |
2008-10-09 |
Mitsubishi Tanabe Pharma Corp |
医薬組成物
|
AU2008268667A1
(en)
|
2007-06-22 |
2008-12-31 |
Merck & Co., Inc. |
6.5-pyrrolopiperidine tachykinin receptor antagonists
|
KR101630884B1
(ko)
*
|
2008-02-26 |
2016-06-15 |
산도즈 아게 |
모르폴린 유도체의 제조
|
US20100098772A1
(en)
|
2008-10-21 |
2010-04-22 |
Allergan, Inc. |
Drug delivery systems and methods for treating neovascularization
|
MY159393A
(en)
*
|
2009-11-18 |
2016-12-30 |
Helsinn Healthcare Sa |
Compositions for treating centrally mediated nausea and vomiting
|
US9197705B2
(en)
|
2013-04-12 |
2015-11-24 |
Samsung Electronics Co., Ltd. |
Method and apparatus for supporting driving using wireless communication network and system thereof
|
US11935003B2
(en)
|
2019-05-23 |
2024-03-19 |
Capital One Services, Llc |
Jailed environment restricting programmatic access to multi-tenant data
|